MedPath

Odonate Therapeutics, Inc.

Ownership
-
Employees
-
Market Cap
-
Website

The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors

Phase 1
Terminated
Conditions
Advanced Solid Tumors
Interventions
First Posted Date
2020-03-18
Last Posted Date
2021-07-28
Lead Sponsor
Odonate Therapeutics, Inc.
Target Recruit Count
93
Registration Number
NCT04312282
Locations
🇺🇸

NEXT Oncology, San Antonio, Texas, United States

🇺🇸

Mary Crowley Cancer Research, Dallas, Texas, United States

🇺🇸

START Midwest, Grand Rapids, Michigan, United States

Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC

Phase 2
Terminated
Conditions
Breast Cancer
Interventions
First Posted Date
2019-05-16
Last Posted Date
2021-07-30
Lead Sponsor
Odonate Therapeutics, Inc.
Target Recruit Count
294
Registration Number
NCT03952325
Locations
🇺🇸

West Cancer Center, Germantown, Tennessee, United States

🇸🇬

National Cancer Centre Singapore, Singapore, Singapore

🇺🇸

Sarah Cannon Research Institute - Florida Cancer Specialists, Fort Myers, Florida, United States

and more 8 locations

Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC

Phase 2
Terminated
Conditions
Breast Cancer
Interventions
First Posted Date
2019-03-01
Last Posted Date
2021-07-30
Lead Sponsor
Odonate Therapeutics, Inc.
Target Recruit Count
152
Registration Number
NCT03858972
Locations
🇺🇸

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States

🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

🇨🇦

Hopital Maisonneuve-Rosemont, Montréal, Canada

and more 22 locations

Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC

Phase 3
Terminated
Conditions
Breast Cancer
Interventions
First Posted Date
2017-10-31
Last Posted Date
2021-07-30
Lead Sponsor
Odonate Therapeutics, Inc.
Target Recruit Count
685
Registration Number
NCT03326674
Locations
🇺🇸

Cancer Treatment Centers of America - Western Regional Medical Center, Goodyear, Arizona, United States

🇺🇸

Arizona Oncology Associates, P.C. - HOPE, Tucson, Arizona, United States

🇺🇸

Ironwood Cancer and Research Centers, Chandler, Arizona, United States

and more 202 locations
© Copyright 2025. All Rights Reserved by MedPath